New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) reveals that menopause may significantly influence how ...
The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...
New research (the Ver-A-T1D trial) presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...
At the Medical Academy of Pediatrics and Special Needs (MAPS) Annual Conference in Phoenix, nearly one thousand pediatricians ...
ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced that results on givinostat for the treatment of Duchenne muscular dystrophy (DMD) are being presented at the 2025 Neuromuscular ...
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced that following a pre-specified interim ...
Introduction Mental health issues such as depression and anxiety are highly and disproportionally prevalent among university ...
Introduction The COVID-19 pandemic led to major disruptions in society across many spheres, including healthcare, the economy and social behaviours. While early predictions warned of an increased risk ...
Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...
Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistant and Refractory Ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results